COMPANY · NIPC 510664040

RUBEASPHARMA

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

41 contracts on Portal BASE, worth €123,127.04 in total.

Follow (RSS) · What is RSS?

Identification

Company nameRUBEASPHARMA
NIPC510664040

None of the registers we read (GLEIF, TED and contract documents) identifies this company; the name comes from Portal BASE contracts.

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2015 to 2021. The table below gives the same values.2015: €10,359.0220152016: €29,285.5720162017: €20,598.6020172018: €12,609.7520182019: €30,204.6420192020: €18,284.4620202021: €1,7852021€30,204.64
Contracted value by year
YearContractsContract value
20157€10,359.02
20166€29,285.57
20178€20,598.60
20188€12,609.75
20196€30,204.64
20205€18,284.46
20211€1,785
Contracted value by place of performance
NameContractsContract value
Leiria7€37,630.84
Lisboa6€31,570.98
Faro6€25,949.51
Coimbra3€12,719.08
Vila Nova de Gaia9€10,051.54
Beja5€4,653.89
Elvas4€409.20
Largest contracts
SubjectYearContract value
E1/00001293/2019 Lauromacrogol 4002019€9,964
POLIDOCANOL 20 MG/2 ML SOL INJ, POLIDOCANOL 60 MG/2 ML SOL INJ, POLIDOCANOL 10 MG/2 ML SOL INJ e POLIDOCANOL 40 MG/2 ML SOL INJ2016€9,324
Medicamentos Exclusivos Rubeaspharma2017€7,318.80
Aquisição de POLIDOCANOL 10 MG/2 ML + 20 MG/2 ML + 40 MG/2 ML + 60 MG/2 ML SOL INJ (LAUROMACROGOL 400)2020€7,224.50
Aquisição de Polidocanol 10mg/2ml sol. inj., Polidocanol 20mg/2ml sol. inj., Polidocanol 40 mg/2ml sol. inj. e Polidocanol 60mg/2ml sol. inj, (Lauromacrogol 400)2019€6,786.92

Who they competed with

In 70 contracts with a list of competitors, the company took part and was awarded 0 (0%).

Companies with the most procedures in common
CompanyProcedures in common
UCB Pharma Lda6
Farmoz Soc Tecnico Medicinal S A6
Hikma, Lda.6
Alloga, S.A.6
Sandoz Farmacêutica, Lda.6
TEVA-PHARMA - PRODUTOS FARMACÊUTICOS, LDA.6
Generis Farmacêutica, S.A.6
Labesfal, S.A.5
Accord Healthcare, Unipessoal5
Orionfin Unipessoal, Lda.5
Merck Sharp & Dohme, Lda4
MYLAN, LDA.4
Overpharma, Lda4
Bluepharma, S.A.4
Novartis3
Prospa, S.A:3
Glaxo SmithKline - Produtos Farmacêutico, Lda.3
Tecnifar-Industria Técnica Farmacêutica, S.A.3
MEDINFAR3
Zentiva Portugal, Lda.3
LABORATÓRIOS NORMON,S.A.3
Grunenthal, S.A.2
Roche Farmacêutica Química, Lda.2
Organon Portugal, Sociedade Unipessoal Lda2
DLA FARMACÊUTICA, S.A.2
FRESENIUS KABI PHARMA PORTUGAL,LDA2
OM PHARMA S.A1
Tecnimede1
B BRAUN MEDICAL, LDA1
Italfarmaco1

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents55 companies and 60 links. The list below gives the same content as text.NIPC 500006148 (NIPC 500006148)NIPC 500006148NIPC 500048193 (NIPC 500048193)NIPC 500048193Novartis (NIPC 500063524)NovartisNIPC 500069190 (NIPC 500069190)NIPC 500069190Grunenthal, S.… (NIPC 500101965)Grunenthal, S.…Glaxo SmithKli… (NIPC 500139962)Glaxo SmithKli…Merck Sharp & … (NIPC 500191360)Merck Sharp & …Roche Farmacêu… (NIPC 500233810)Roche Farmacêu…UCB Pharma Lda (NIPC 500291322)UCB Pharma LdaB BRAUN MEDICA… (NIPC 501506543)B BRAUN MEDICA…NIPC 510664040 (NIPC 510664040)NIPC 510664040+44 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

48 more links

Investigations that mention it

No published investigation mentions this company by NIPC.